Literature DB >> 3548890

Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain.

C Gall, J Lauterborn, D Burks, K Seroogy.   

Abstract

A double-label immunofluorescence technique was used to demonstrate that immunoreactivities for the functionally antagonistic neuropeptides enkephalin and cholecystokinin octapeptide (CCK) are co-localized within individual neurons and processes in discrete areas of rat midbrain and forebrain. Coexistence was most prominent within varicose pericellular axons extending from the periaqueductal gray matter to a field overlying the medial lemniscus, axons and terminal-like puncta in the central medial, paracentral, interanterodorsal and ventral anterior thalamic nuclei, and perikarya and proximal axonal fragments in layers II and III of neo- and allocortex, and in the anterior olfactory nucleus. The former two systems of axons lie in areas of spinothalamic tract termination. These data suggest that some of the antagonism of opioid analgesia by CCK occurs at the synaptic level in nociceptive areas of brain-stem and thalamus where CCK and enkephalin are co-localized and presumably co-released.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548890     DOI: 10.1016/0006-8993(87)90085-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Electroacupuncture modulation of reflex hypertension in rats: role of cholecystokinin octapeptide.

Authors:  Min Li; Stephanie C Tjen-A-Looi; Zhi-Ling Guo; John C Longhurst
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-19       Impact factor: 3.619

2.  The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

Authors:  O Valverde; M C Fournie-Zaluski; B P Roques; R Maldonado
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

3.  Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.

Authors:  Blandine Pommier; Françoise Beslot; Axelle Simon; Matthieu Pophillat; Toshimitsu Matsui; Valérie Dauge; Bernard P Roques; Florence Noble
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

4.  Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.

Authors:  C Smadja; R Maldonado; S Turcaud; M C Fournie-Zaluski; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

5.  Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.

Authors:  L Singh; R J Oles; M J Field; P Atwal; G N Woodruff; J C Hunter
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  Genetic analysis of a population heavy drinking phenotype identifies risk variants in whites.

Authors:  Ajna Hamidovic; Robert J Goodloe; Taylor R Young; Mindi A Styn; Kenneth J Mukamal; Helene Choquet; Jay L Kasberger; Sarah G Buxbaum; George J Papanicolaou; Wendy White; Kelly Volcik; Bonnie Spring; Brian Hitsman; Daniel Levy; Eric Jorgenson
Journal:  J Clin Psychopharmacol       Date:  2013-04       Impact factor: 3.153

7.  Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain.

Authors:  F Noble; M Derrien; B P Roques
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  The roles of nerve growth factor and cholecystokinin in the enhancement of morphine analgesia in a rodent model of central nervous system inflammation.

Authors:  Dimitris N Xanthos; Naresh Kumar; Elvar Theodorsson; Terence J Coderre
Journal:  Neuropharmacology       Date:  2008-12-11       Impact factor: 5.250

9.  Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors.

Authors:  Alar Veraksits; Kertu Rünkorg; Kaido Kurrikoff; Sirli Raud; Urho Abramov; Toshimitsu Matsui; Michel Bourin; Sulev Kõks; Eero Vasar
Journal:  Psychopharmacology (Berl)       Date:  2003-01-24       Impact factor: 4.530

10.  Multiple peptide immunoreactivities in the nervous system of Aeschna cyanea (Insecta, Odonata). An immunohistochemical study using antisera to cholecystokinin octapeptide, somatoliberin, vasoactive intestinal peptide, motilin and proctolin.

Authors:  J C Andriès; G Belemtougri; G Tramu
Journal:  Histochemistry       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.